Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.
The US city of Seattle has become the largest city in the country to decriminalize the use of some psychedelic substances, including psilocybin and mescaline.
Ketamine alone may be just as effective as ketamine combined with traditional antidepressants for tackling treatment-resistant depression, a new study has found.
Gül Dölen, an associate professor of neuroscience at Johns Hopkins University, explained to Analytical Cannabis just how MDMA-assisted psychotherapy can reopen a “critical period” in the brain for social reward learning.
Analytical Cannabis breaks down the traits and effects of the most commonly sought after psychedelic mushrooms.